DE3873855D1 - Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten. - Google Patents

Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.

Info

Publication number
DE3873855D1
DE3873855D1 DE8888104336T DE3873855T DE3873855D1 DE 3873855 D1 DE3873855 D1 DE 3873855D1 DE 8888104336 T DE8888104336 T DE 8888104336T DE 3873855 T DE3873855 T DE 3873855T DE 3873855 D1 DE3873855 D1 DE 3873855D1
Authority
DE
Germany
Prior art keywords
kidney
mixture
treatment
bone diseases
related bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888104336T
Other languages
English (en)
Other versions
DE3873855T2 (de
Inventor
Mordecai Popovtzer
Ben Zion Weiner
Shmuel Edelstein
Zeev Mazor
David Ladkani
Benjamin Shalita
John Anthony Kanis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22132162&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3873855(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of DE3873855D1 publication Critical patent/DE3873855D1/de
Application granted granted Critical
Publication of DE3873855T2 publication Critical patent/DE3873855T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8888104336T 1987-07-22 1988-03-18 Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten. Revoked DE3873855T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/076,459 US4997824A (en) 1987-07-22 1987-07-22 Combination of cholecalciferol derivatives for the treatment of renal bone disease

Publications (2)

Publication Number Publication Date
DE3873855D1 true DE3873855D1 (de) 1992-09-24
DE3873855T2 DE3873855T2 (de) 1993-01-14

Family

ID=22132162

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888104336T Revoked DE3873855T2 (de) 1987-07-22 1988-03-18 Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.

Country Status (6)

Country Link
US (1) US4997824A (de)
EP (1) EP0301167B1 (de)
JP (1) JPS6431722A (de)
AU (1) AU604534B2 (de)
DE (1) DE3873855T2 (de)
ZA (1) ZA881307B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74617A (en) * 1985-03-15 1988-11-15 Yeda Res & Dev Compositions comprising a vitamin d derivative and method for the local treatment of bone fractures in animals
US4948789A (en) * 1989-03-28 1990-08-14 Chugai Seiyaku Kabushiki Kaisha Suppression of parathyroid hormone synthesis and secretion
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
AU666529B2 (en) * 1992-04-24 1996-02-15 Wisconsin Alumni Research Foundation Method of treating osteoporosis with 1 alpha, 24 (R)-dihydroxy-22 (E)-dehydro-vitamin D3
KR960013798B1 (ko) * 1992-04-24 1996-10-10 재단법인 한국전자통신연구소 평면 도파로형 공간 스위치
JP2876547B2 (ja) * 1992-06-23 1999-03-31 呉羽化学工業株式会社 抗クル病剤
US6291444B1 (en) 1993-06-16 2001-09-18 Wisconsin Alumni Research Foundation Treatment of t-cell immunodeficiencies with vitamin D compounds
JP2684587B2 (ja) * 1993-06-21 1997-12-03 呉羽化学工業株式会社 腎性骨異栄養症における骨量減少抑制剤
KR950000153A (ko) * 1993-06-21 1995-01-03 아라끼 타다시 신성골이영양증(Renal Osteodystrophy)의 골질량감소 억제제
US5552392A (en) * 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
EP0897300A4 (de) * 1995-10-10 2000-07-05 Marilyn Strube Behandlung von pruritus mit vitamin d und dessen analogen
DK3095447T3 (da) 2006-02-03 2022-01-31 Opko Renal Llc Behandling af vitamin d-insufficiens og -mangel med 25-hydroxyvitamin d2 og 25-hydroxyvitamin d3
CA2655499C (en) 2006-06-21 2015-10-27 Proventiv Therapeutics, Llc Method of treating and preventing secondary hyperparathyroidism_with vitamin d repletion and vitamin d replacemnt therapies
EP3542792B1 (de) 2007-04-25 2023-06-28 EirGen Pharma Ltd. Kontrollierte freisetzung 25-hydroxyvitamin d
ES2403107T3 (es) 2007-04-25 2013-05-14 Cytochroma Inc. Método de tratamiento de insuficiencia y deficiencia de vitamina D
US20100144684A1 (en) 2007-04-25 2010-06-10 Proventiv Therapeutics, Inc. Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease
CN106853250A (zh) 2008-04-02 2017-06-16 赛特克罗公司 用于维生素d缺乏症和相关障碍的方法、组合物、用途和试剂盒
EP2201937A1 (de) * 2008-12-23 2010-06-30 Teva Pharmaceutical Industries Ltd. Formulierungen enthaltend Vtamin Doder ein Derivativ davon
CN105796530A (zh) 2010-03-29 2016-07-27 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
KR20170047265A (ko) 2014-08-07 2017-05-04 옵코 아일랜드 글로벌 홀딩스 리미티드 25-하이드록시비타민 d를 이용한 보조요법
EP3053598A1 (de) 2015-02-06 2016-08-10 Faes Farma, S.A. Calcifediol-Weichkapseln
EP3436026A1 (de) 2016-03-28 2019-02-06 OPKO Ireland Global Holdings, Ltd. Verfahren zur vitamin-d-behandlung

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3715374A (en) * 1972-05-05 1973-02-06 Wisconsin Alumni Res Found 24,25-dihydroxycholecalciferol
JPS603045B2 (ja) * 1976-04-19 1985-01-25 中外製薬株式会社 １α―ヒドロキシビタミンＤ類軟カプセルの製造方法
JPS5312414A (en) * 1976-07-21 1978-02-03 Chugai Pharmaceut Co Ltd Production of preparation containing stable 1alpha-hydroxyvitamines d
JPS55136229A (en) * 1979-04-10 1980-10-23 Teijin Ltd Adjustment of bone metabolism in warm-blooded animal and drug for it
JPS55139320A (en) * 1979-04-16 1980-10-31 Teijin Ltd Bone metabolism regulator
JPS5626819A (en) * 1979-08-10 1981-03-16 Chugai Pharmaceut Co Ltd Preventive for hypoimmunity
AU532512B2 (en) * 1979-09-07 1983-10-06 Upjohn and Horton Anti-allergenic compounds for bone mineral resorption
JPS56138168A (en) * 1980-03-31 1981-10-28 Teijin Ltd Movel active vitamin d3 derivative composition
JPS5740461A (en) * 1980-08-25 1982-03-06 Teijin Ltd Novel activated vitamin d3 derivative composition
US4442093A (en) * 1981-05-15 1984-04-10 Kureha Kagaku Kogyo Kabushiki Kaisha Method for administering 24,25-dihydroxycholecalciferol to persons suffering from hypercalcemia
JPS6089422A (ja) * 1983-10-24 1985-05-20 Kureha Chem Ind Co Ltd 抗骨粗鬆症剤
JPS61129130A (ja) * 1984-11-27 1986-06-17 Kureha Chem Ind Co Ltd 抗尿毒症剤
CA1317546C (en) * 1985-07-01 1993-05-11 Werner Meier Pharmaceutical preparations containing mixtures of hydroxy derivatives of vitamin d
JPS6391323A (ja) * 1986-10-03 1988-04-22 Kureha Chem Ind Co Ltd 抗尿路結石症剤

Also Published As

Publication number Publication date
AU1274788A (en) 1989-01-27
AU604534B2 (en) 1990-12-20
ZA881307B (en) 1988-12-14
EP0301167B1 (de) 1992-08-19
JPS6431722A (en) 1989-02-02
US4997824A (en) 1991-03-05
DE3873855T2 (de) 1993-01-14
EP0301167A1 (de) 1989-02-01

Similar Documents

Publication Publication Date Title
DE3873855D1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.
OA08581A (en) Treatment of diseases caused by retroviruses.
ATE82121T1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
NL194748B (nl) Osmotische doseringsvorm voor behandeling van cardiovasculaire ziekten.
ATE33098T1 (de) Celiprolol zur behandlung von glaukom.
DE3587741D1 (de) Behandlung von Hautkrankheiten.
ES278010Y (es) Clavo oseo, especialmente clavo de boqueo, para el tratamiento de fracturas de hueso
DE3685633D1 (de) Behandlung von knochenstoerungen.
DE3882642D1 (de) Substituierte tetraline, chromane und verwandte verbindungen fuer die behandlung von asthma, arthritis und verwandte krankheiten.
ES2013631B3 (es) Metodo para el tratamiento de tejidos.
BG94738A (bg) Използване на разтвор на йод за лечение на заболявания, свързани с йодна недостатъчност
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
ATE11013T1 (de) Heilmittelzusammensetzungen zur behandlung der haut.
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
ZA875847B (en) Pharmaceutical compositions for the treatment of occlusive vascular diseases
NO880292D0 (no) Fremgangsmaate for behandling av humle.
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
ATE79541T1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.
DE3866653D1 (de) Zusammensetzung fuer die behandlung der epidermis.
DE68918449D1 (de) Siliziumverbindungen zur behandlung von knochen.
DE3668338D1 (de) Kontinuierliche behandlung von spannungslosem gewebe.
NO884635L (no) Fremgangsmaate for behandling av voerter.
DE68905479D1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.
ATE86857T1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation